HVTN 142

Phase 1, HIV

This study is assessing the Safety, Reactogenicity and Immunogenicity of VIR-1388 (an HIV vaccine candidate) compared with Placebo in Healthy Participants without HIV between the ages of 18 to 55. This study is currently enrolling participants.

Name*
First Last
Email*
Phone*
Consent
I would like to receive information on other Center for Virology and Vaccine Research studies.
Which study are you interested in?*
How did you hear about this study?*
If you learned about our study through other means, please specify here.
Preferred method of contact*
- Phone
- Email
- Either
CAPTCHA

HVTN 142

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates